期刊文献+

以高敏C-反应蛋白作为动脉粥样硬化气虚血淤病机辨证的标志物的理论探讨 被引量:2

Study on Hs-CRP as the Marker of Pathogenesis of Qi-deficiency and Blood-stagnation in Atherosclerasis
下载PDF
导出
摘要 动脉粥样硬化(AS)是一种炎性疾病,主要以潜证方式存在于健康人群,气虚血瘀是AS潜证的病机关键。CRP参与了AS炎症发生发展的全过程,并是AS相关心脑血管疾病的独立危险因素和预测指标,因此,我们提出以hs-CRP作为AS气虚血淤病机辨证的筛查指标,高hs-CRP的患者如果AS的常规检查异常,建议结合病人体质应用益气活血法辨治预防AS。该项工作将有助于开展AS的中医防治工作,深化中医的治未病思想。 AS is an inflammatory disease which exists in " healthy" people as a dormant syndrome. Qi-deficiency and Bloodstagnation is the main pathogenesis of AS. C-reactive protein (CRP) participates in the occurrence and progress of AS. It is the independent risk factor and prognostic index of AS. We propose that high sensitivity CRP (hs-CRP) should be the screen marker of pathogenesis of Qi-deficiency and Blood-stagnation. If the high hs-CRP case have abnormality in routine examination of AS, We suggest that use the treatment based on syndrome differentiation based on replenishing Qi and activating blood circulation which combined with the pathogenesis and the physic of the patient. This work would help to prevent and therapy AS with TCM and deep the orinciole of "oreventive treatment before the occurrence of diseases".
出处 《时珍国医国药》 CAS CSCD 北大核心 2007年第6期1349-1350,共2页 Lishizhen Medicine and Materia Medica Research
基金 广东省自然科学基金博士启动基金项目(No.05300461) 广东省自然科学基金自由申请项目(No.06024430) 广东省中医药局基金课题(No.1040088)
关键词 高敏C-反应蛋白 动脉粥样硬化 气虚血淤 hs-CRP Atherosclerosis Qi-deficiency and Blood-stagnation
  • 相关文献

参考文献10

  • 1Ross R.Atherosclerosis-an inflammatory disease[J].N Engl J Med.1999,340(2):115.
  • 2Binder CJ,Chang MK,Shaw PX,et al.Innate and acquired immunity in atherogenesis[J].Nat Med.2002,8 (11):1218.
  • 3邵致格,胡曼菁,王长松.现代人群的体质病理学特征:气虚血瘀[J].医学与哲学,2005,26(4):74-75. 被引量:25
  • 4颜德馨,胡泉林,王平平,周晓燕,宓哲伟,周良彦.气虚血瘀是人体衰老的主要机制[J].中国医药学报,1989,4(2):10-12. 被引量:112
  • 5梁煜,林代华,王清.气虚血瘀是冠心病的病机关键释义[J].中医药学刊,2003,21(4):588-588. 被引量:64
  • 6刘洪,李荣亨.气虚血瘀证与血管内皮细胞相关因子的研究进展[J].中国中医基础医学杂志,2005,11(7):553-556. 被引量:26
  • 7温武兵,张珍玉.论宗气的生理功能[J].山东中医药大学学报,2000,24(4):247-250. 被引量:45
  • 8Jialal I,Devaraj S,Venugopal SK.C-Reactive Protein:Risk Marker or Mediator in Atherothrombosis[J].Hypertension.2004,44 (1):6.
  • 9Biasucci LM.CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases:A Background Paper[J].Circulation.2004,110(25):e560.
  • 10Ridker PM;JUPITER Study Group.Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of lowdensity lipoprotein cholesterol and elevated high-sensitivity C-reactive protein:rationale and design of the JUPITER trial[J].Circulation.2003,108 (19):2292.

二级参考文献70

  • 1宋崇顺.从防治冠心病心绞痛探讨补气药在益气活血治则中的地位[J].辽宁中医杂志,1987(5):42-44. 被引量:24
  • 2宋崇顺 等.气虚证血液流变学的临床观察和实验研究[J].中医杂志,1981,(10):39-39.
  • 3张介宾.景岳全书[M].上海:上海科学技术出版社,1959.332.
  • 4廖家桢 武泽民 等.生脉散对冠心病心绞痛患者左心室功能的影响[J].中医杂志,1981,(6):24-27,30.
  • 5石寿棠.医原[M].南京:江苏科学技术出版社,1983.52.
  • 6张珍玉.读内经札记(四)[J].山东中医学院学报,1984,(3):53-53.
  • 7李杲.脾胃论[M].沈阳:辽宁科学技术出版社,1997.22.
  • 8李杲.东坦试效方[M].上海:上海科学技术出版社,1984.341.
  • 9陈俊杰 廖家侦 武泽民 等.益气活血法治疗冠心病心绞痛的临床研究.中国中西医结合杂志,1985,5(11):658-662.
  • 10何熹延,何吟锦.冠心病心绞痛中医治疗法则及其疗效原理研究进展[J].中医药信息,1997,14(3):8-10. 被引量:21

共引文献248

同被引文献49

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部